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Abstract: (1) Background: Human transient receptor potential (TRP) channels constitute a large
family of ion-conducting membrane proteins that allow the sensation of environmental cues. As the
dysfunction of TRP channels contributes to the pathogenesis of many widespread diseases, including
cardiac disorders, these proteins also represent important pharmacological targets. TRP channels
are typically produced using expensive and laborious mammalian or insect cell-based systems.
(2) Methods: We demonstrate an alternative platform exploiting the yeast Saccharomyces cerevisiae
capable of delivering high yields of functional human TRP channels. We produce 11 full-length
human TRP members originating from four different subfamilies, purify a selected subset of these to
a high homogeneity and confirm retained functionality using TRPM8 as a model target. (3) Results:
Our findings demonstrate the potential of the described production system for future functional,
structural and pharmacological studies of human TRP channels.
Keywords: ion channels; overproduction; production platform; protein purification; Saccharomyces
cerevisiae; sensors; transient receptor potential (TRP) channels; yeast
1. Introduction
Transient receptor potential (TRP) channels constitute one of the largest families of ion channels
and serve as cellular sensors that permeate cations, such as calcium, magnesium and sodium,
in response to physical or chemical stimuli. Human TRP channels are widely expressed throughout
the body, including brain, heart, liver, lung, small and large intestine, skeletal muscle, skin, pancreas,
as well as in inflammatory and immune cells [1,2]. Changes of temperature, pH, the concentration
of chemicals or membrane potential modulate TRP channel activity, highlighting their essential
physiological roles in the sensation of thermal shifts [3], pain [4], taste [5] and pressure [6]. Malfunction
of TRP channels significantly contributes to the development of many pathological conditions,
including bipolar disorder, diabetes mellitus, various types of cancer, coronary heart disease and
muscular dystrophia [7]. Consequently, TRP channels represent attractive pharmacological targets and
indeed several TRP-modulating compounds currently undergoing clinical trials [8].
Based on sequence homology, topology and function, human TRP channels are divided into six
subfamilies (Figure 1A): TRPC (canonical), TRPV (vanilloid), TRPM (melastatin), TRPA (ankyrin),
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TRPP (polycystin) and TRPML (mucolipin). Moreover, two additional subfamilies, i.e., TRPN and
TRPY have been identified in Drosophila melanogaster and yeast, respectively. Structurally, TRP channels
assemble as homo- or hetero-tetramers with a single pore formed in the center. Each subunit consists
of intracellular N- and C-termini, six transmembrane helices (TM1-TM6) interconnected by relatively
short loops, with a pore forming loop (P) inserted between the TM5 and TM6 (Figure 1B,C) [9,10].
Currently, several structures are available for the TRP family (Table 1), including TRPA [11],
TRPPP2-3 [12,13], TRPV1-6 [14–19], TRPC3-6 [20–24], TRPML1 and 3 [25,26], as well as TRPM2,
4 [27,28] and 7-8 [29,30] from different species. In addition to revealing the overall architectures,
the gathered structural information provided mechanistic insights explaining fundamental regulatory
and functional mechanisms [9,31], as well as facilitated drug development, with, e.g., TRPV1 being a
highly medically relevant target [32].
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Figure 1. Human transient receptor potential (TRP) channels. (A) Phylogenetic distribution of the
human TRP channel family including six subfamilies comprising proteins with distinct channel
properties. Protein sequences were aligned using MEGA7 (https://www.megasoftware.net/).
Structurally determined channels are highlighted with stars (not all structures were of protein with
human origin, s e also Table 1). (B) Topology of TRP c annels showing in detail distinct architecture
of the intracellular N- and C-termini across TRP channel subfamilies. (C) Overall structure of TRP
channels with three out of the four monomers shown in pale colors (the structure of TRPV1, PDB-ID:
3J5P [14], as used as a model). TRP chann l monomers consist of ix transmembrane helices (TM1 to
TM6) that assemble as tetramers with a single ion conducting central pore in the center formed by 5,
TM6 and the interconnecting pore-loop (P).
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Being membrane proteins, many types of studies of TRP channels are nevertheless hindered
by the difficulty of producing protein samples of sufficient quantity and quality in an economically
sustainable manner. Systematic analysis of heterologous expression systems utilized for production
of TRP channels for structural studies reveals that mammalian and insect cell-based platforms are
the most commonly used (Table 1). TRPV1 [14], TRPM2 [27] and TRPV3 [16] channels were isolated
from modified human HEK cells, whereas TRPML3 was overproduced using an insect (Sf9) cell-based
platform [26]. To our knowledge, yeast, i.e., Saccharomyces cerevisiae, has been exploited to deliver
the structures of two TRP channels only, namely TRPV2 from Rattus norvegicus [15] and TRPV5
from Oryctolagus cuniculus [18], whereas no structure is available originating from a bacterial host,
despite attempts [33].
For many researchers, the primary expression system, also for the production of integral
membrane proteins, has traditionally been Escherichia coli, due to the ease of genetic manipulation,
availability of optimized expression plasmids, high-speed of growth and low cost [34,35]. However,
generation of many proteins from higher sources frequently requires a eukaryotic expression system,
such as insect, mammalian or yeast as hosts [36]. Compared to E. coli, the establishment of insect
or mammalian cell-derived expression is nevertheless cost- and time-consuming. In this context,
S. cerevisiae has advantages as it offers a cheap and robust large-scale production of properly-folded
proteins with post-translational modifications combined with user-friendly genetic manipulations
and simple culture conditions [36–38]. Hence, yeast represents an attractive complement for
synthesis of high-quality protein, which has potential to permit in-depth biophysical and biochemical
characterization, as well as drug discovery of many important targets, including TRP channels, for basic
and applied sciences.
Here, we describe the development of an economic and effective method to isolate purified,
functional human TRP channels applying a previously described robust S. cerevisiae membrane protein
production platform [34,36,37]. Briefly, we approached 11 selected human TRP members belonging
to 4 different subfamilies and produced these as full-length channels C-terminally fused to green
fluorescent protein (GFP). We proceeded further with one member from each subfamily, i.e., TRPC4,
TRPV3, TRPML2 and TRPM8, screened for suitable detergents for membrane extraction and assessed
the quality of the solubilized samples by florescence-detection size-exclusion chromatography (F-SEC).
Subsequently, we performed large-scale purification using affinity chromatography and investigated
homogeneity of the samples employing SEC. Finally, for TRPM8, a medically significant target for
the development of drugs to treat cold-associated respiratory disorders [39] and prostate cancer,
respectively [40], we confirmed retained channel function following reconstitution into artificial lipid
bilayers. Overall, our results suggest that S. cerevisiae is suitable for obtaining large-scales of active
human TRP channels for numerous down-stream applications.
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Table 1. Structurally determined TRP channels. TRP channels produced in Saccharomyces cerevisiae are framed. Targets included in this study are indicated in colors
(yellow, green, blue and red represent TRPC, TRPV, TRPML and TRPM subfamilies, respectively). Boxes indicate the recombinant proteins produced in yeast, targets
purified in this study are shown in bold. Additional information about constructs, structure determination method and obtained resolution are also shown.
Target Organism Expression System Full Length Truncation Structure DeterminationMethod
Resolution
Å
TRPC3 Homo sapiens Homo sapiens (AD-HEK293) x cryo-EM 4.4
TRPC4 Mus musculus Spodoptera frugiperda x cryo-EM 3.3
TRPC5 Mus musculus Homo sapiens (HEK293S) x cryo-EM 2.9
TRPC6 Mus musculus Spodoptera frugiperda x cryo-EM 3.8
TRPC6 Homo sapiens Homo sapiens (AD-HEK293) x cryo-EM 3.8
TRPV1 Rattus norvegicus Homo sapiens (HEK293S) minimal function cryo-EM 4.2
TRPV2 Rattus norvegicus Saccharomyces cerevisiae x cryo-EM 4.4
TRPV2 Oryctolagus cuniculus Spodoptera frugiperda x cryo-EM 3.8
TRPV2 Oryctolagus cuniculus Spodoptera frugiperda minimal function X-ray 3.9
TRPV3 Mus musculus Homo sapiens (HEK293S) x cryo-EM 4.3
TRPV4 Xenopus tropicalis Pichia pastoris x cryo-EM 3.8
TRPV5 Oryctolagus cuniculus Saccharomyces cerevisiae x cryo-EM 3.9
TRPV6 Rattus norvegicus Homo sapiens (HEK293S) x X-ray 3.2
TRPV6 Homo sapiens Homo sapiens (HEK293S) x cryo-EM 3.6
TRPML1 Homo sapiens Homo sapiens (HEK293S) x cryo-EM 3.7
TRPML3 Callithrix jacchus Spodoptera frugiperda x cryo-EM 2.9
TRPM2 Danio rerio Homo sapiens (HEK293S) x cryo-EM 3.3
TRPM4 Homo sapiens Homo sapiens (HEK293F) x cryo-EM 3.2
TRPM7 Mus musculus Homo sapiens (HEK293S) x cryo-EM 3.3
TRPM8 Ficedula albicollis Homo sapiens (HEK293S) x cryo-EM 4.1
TRPA1 Homo sapiens Homo sapiens (HEK293) x cryo-EM 4.2
TRPP2 Homo sapiens Homo sapiens (HEK293S) x cryo-EM 4.2
TRPP3 Homo sapiens Homo sapiens (HEK293S) x cryo-EM 3.1
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2. Materials and Methods
2.1. Cloning and Construction of Plasmids
All cDNAs encoding full-length human TRP channels were codon-optimized for S. cerevisiae and
purchased from GenScript (New Jersey, NJ, USA). Codon-optimization algorithm involves adjustment
of a variety of parameters, including codon adaptability, mRNA structure, and various cis-elements
critical in transcription and translation. TRP channel cDNAs and GFP were PCR amplified with
AccuPol DNA polymerase (Amplicon, Odense, Denmark) and the primers listed in Supplementary
Table S1. Each TRP channel-GFP-His8 fusion was generated by homologous recombination by
co-transforming the S. cerevisiae PAP1500 strain [41] with a TRP PCR fragment, a GFP PCR fragment,
as well as BamHI, HindIII and SalI digested pEMBLyex4 vector [42]. The PCR primers were designed
to encode a Tobacco Etch Virus (TEV) protease cleavage site (GENLYFQ↓SQF) between the TRP channel
and the GFP-octa-histidine (His8)-tag. Transformants were selected on agar plates containing synthetic
defined (SD) medium with leucine (60 mg L−1) and lysine (30 mg L−1). The accuracy of all constructs
was confirmed by DNA sequencing.
2.2. Small-Scale Expression of TRP Channels and Live Cell Bioimaging
All TEV-GFP-His8-fusions were expressed in the S. cerevisiae strain PAP1500 essentially as
previously described [43]. Briefly, transformants were inoculated in 5 mL of SD media [44] containing
glucose (20 g L−1), leucine (60 mg L−1) and lysine (30 mg L−1), and grown overnight at 30 ◦C.
The following day, 200 µL of the culture was transferred to 5 mL of the same media lacking leucine
and grown for 24 h at 30 ◦C to increase plasmid copy number upon leucine deprivation. Subsequently,
5 mL of the culture was scaled up to 50 mL in the same medium for another 24 h and used to
inoculate 2 L of media supplemented with amino acid (alanine (20 mg L−1), arginine (20 mg L−1),
aspartic acid (100 mg L−1), cysteine (20 mg L−1), glutamic acid (100 mg L−1), histidine (20 mg L−1),
lysine (30 mg L−1), methionine (20 mg L−1), phenylalanine 50 mg L−1), proline (20 mg L−1), serine
(375 mg L−1), threonine (200 mg L−1), tryptophan (20 mg L−1), tyrosine (30 mg L−1) and valine
(150 mg L−1)), glucose (10 g L−1) and glycerol (3% v/v). Following glucose consumption, protein
expression was induced by adding galactose to a final concentration of 2% and allowed for 48 h at
15 ◦C until the cells were harvested. Obtained material typically yielded in ~10 g of wet cell pellet.
Localization of expressed TEV-GFP-His8-fused TRP channels was performed by bioimaging of
GFP fluorescence in vivo using the Nikon Eclipse E600 microscope (Nikon, Japan) equipped with a
Optronics MagnaFire camera (Optronics, Muskogee, OK, USA).
2.3. Membrane Preparation, Detergent Screens and F-SEC
S. cerevisiae cells were homogenized mechanically (BioSpec, Bartlesville, OK, USA) using
glass beads and crude membranes were prepared as previously described [45]. Briefly, following
ultracentrifugation (205,000× g, 3 h, 4 ◦C), membranes were resuspended in ice-cold solubilization
buffer (SB; 20 mM Tris-NaOH pH 7.5, 500 M NaCl, 10% glycerol, 1 mM EDTA, 1 mM EGTA)
supplemented with SIGMAFAST protease inhibitor cocktail (Sigma, St. Louis Missouri, MO, USA),
1 mM PMSF (Sigma) and 2 mM 2-mercaptoethanol (Sigma), and stored at −80 ◦C until further
use. Isolated membranes from yeast overexpressing the respective TRP channel were subjected to
detergent screening to test solubilization efficacy. Briefly, solubilization was performed at vigorous
rotation (2 h, 4 ◦C) in SB in the presence of n-dodecyl-D-maltoside (DDM; Anatrace, Maumee,
OH, USA), n-decyl-D-maltoside (DM; Anatrace) or 2,2-didecylpropane-1,3-bis-β-D-maltopyranoside
(LMNG; Anatrace) in a final concentration of 2% (1:1 detergent-to-membrane mass ratio) or
n-dodecylphosphocholine (FC-12; Anatrace) or n-heksadecylphosphocholine (FC-16; Anatrace) in a
final concentration of 1% (1:2 detergent-to-membrane mass ratio). Insoluble material was removed
by ultracentrifugation (50,000× g, 20 min, 4 ◦C) and 20 µL of the supernatant was used to measure
GFP fluorescence (excitation 485 nm, emission 520 nm) to estimate detergent extraction efficacy.
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The remaining material was loaded on Superose 6 HR 10/30 column (GE Healthcare, Copenhagen,
Denmark) equilibrated with buffer composed of 20 mM Tris-NaOH pH 7.5, 150 mM NaCl and 0.03%
DDM, and subjected to F-SEC performed on ÄKTA Pure system (GE Healthcare) equipped with a
Prominence RF-20A fluorescence detector (Shimadzu, Kyoto, Japan).
2.4. Large-Scale Protein Production, TEV Protease Cleavage and SEC
Large-scale expression of selected TRP channels was performed in 15-L bioreactors essentially as
previously reported [42]. Briefly, 50 mL of the yeast culture described above was scaled up to 1 L in
the same medium and grown overnight at 30 ◦C. The following day, the culture was used to inoculate
10 L of identical medium supplemented with 3% glucose, 3% glycerol, amino acids (excluding leucine),
inorganic salts and vitamins, and the growth was performed in Applikon fermenters connected to an
ADI 1030 Bio Controller (Applikon Biotechnology, Delft, Netherlands) with the automated maintenance
of culture pH at 6.0. Approximately 18 h after inoculation, 1 L of 20% glucose was added to further
increase the growth of cells. Following glucose consumption, protein expression was induced by
adding galactose to a final concentration of 2% and allowed for 96 h at 15 ◦C until the cells were
harvested. Obtained material typically yielded in ~150–200 g of wet cell pellet.
Large-scale protein purification was performed using immobilized metal ion affinity
chromatography (IMAC) with crude membranes isolated from 40 g of fermenter-grown yeast cells
(obtained from ~3 L of cell culture). Membranes were solubilized by vigorous rotation (3 h, 4 ◦C) in
SB containing the detergent of interest in a final concentration of 2% (DDM or DM) or 1% (FC-16).
Insoluble material was removed by centrifugation (35,000× g, 1 h, 4 ◦C) and the supernatant was loaded
onto a HisTrap HP column (GE Healthcare), washed with 50 mL of IMAC buffer (20 mM Tris-NaOH
pH 7.5, 500 mM NaCl, 10% glycerol and 3 × CMC of the respective detergent). Subsequently, bound
protein was eluted in IMAC buffer supplemented with step-wise (60, 250 and 500 mM) imidazole
gradient. Top IMAC fractions were pooled, concentrated on Vivaspin concentrators (MWCO 100 kDa;
Sartorius, Göttingen, Germany) and the GFP-His8-tag was cleaved with TEV-His10-tagged protease
(home source; 16 h, 4 ◦C) mixed with the protein sample in a ratio of 1:10 (w/w). Treatment with
TEV protease was performed with concomitant dialysis against IMAC buffer supplemented with
20 mM imidazole performed in MWCO 10 kDa dialysis bags (ThermoScientific, Waltham, MA,
USA). Following cleavage with TEV protease, reverse IMAC (RIMAC) was performed to rebind
un-cleaved TEV-GFP-His8-fusions, free GFP-His8-tag and TEV-His10-tagged protease. Briefly, samples
were loaded onto a HisTrap HP column (GE Healthcare) equilibrated with 15 mL of IMAC buffer
containing 20 mM imidazole, and the flow through was collected and concentrated to ~5 mg mL−1 as
already described. Subsequently, RIMAC- or IMAC-pure samples were loaded onto a Superose
6 HR 10/30 column (GE Healthcare) equilibrated with SEC buffer (20 mM Tris-NaOH pH 7.5,
150 mM NaCl, 10% glycerol and 3 × CMC of the respective detergent). Following each SEC run,
fractions corresponding to the main elution peak were pooled and concentrated to ~1 mg mL−1 as
already described.
2.5. Measurements of Single Channel Ion Conductance
Single channel ion conductance was measured in lipid bilayers using an Orbit Mini workstation
(Nanion Technologies, München, Germany) with 50 µm MECA4 recording chips with 4 microelectrode
cavities (Ionera Technologies, Freiburg, Germany) as previously described [46]. Voltage was controlled
by the EDR 3 software (Elements, Cesena, Italy). 150 µL of the recording solution (10 mM HEPES
pH 7.2, 200 mM KCl, 100 mM NaCl and 0.2 mM CaCl2) was added to the cavity of the chip and
electrical contact was established between the electrodes. Lipid planar membranes were formed over
the electrode using 10 mM of 1,2-diphytanoyl-sn-glycero-3-phosphocholine (DPhPc; Avanti Polar
Lipids, Alabaster, AL, USA) and 1 mM cholesterol in n-nonane (Avanti Polar Lipids). DDM-solubilized
SEC-purified TRPM8 sample (0.2 µL of 6.34 µg µL−1) was added to recording solution close to the
bilayers on the cis-side of the chip. Voltage was switched between positive and negative values,
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increasing by 20-mV intervals to stimulate protein insertion into the membrane. To activate TRPM8,
1.0 µL of icilin (Sigma) was added to a final concentration of 0.2 µM. Once channel activity was detected,
voltage steps to −20, −40, −80, −100, 20, 40, 60, 80 and 100 mV were applied. If no activity was
observed after more than 2.5 min, the solution was gently mixed, and if still no activity, an additional
0.2 µL of protein sample was added. All recordings were obtained at room temperature (20–22 ◦C).
Recordings were low-pass filtered at 0.5 kHz and analyzed using Clampfit 10.7 software
(Molecular Devices, San Jose, CA, USA). For single channel events current amplitude was determined.
Single channel current was plotted as a function of voltage (I/V curve) using Prism 7 software
(GraphPad, San Diego, CA, USA) and slope conductance was determined by linear regression.
3. Results
3.1. Selected TRP-Channel Targets and The Expression System
To investigate the capacity of S. cerevisiae to serve as a host for production of human TRP channels,
we selected 11 human members belonging to 4 of the main subfamilies, hence, representing targets
with a variety of distinct structural (e.g., N- and C-termini) and functional features. Specifically,
the portfolio included the following members: TRPC3, TRPC4, TRPC5, TRPV1, TRPV3, TRPV4,
TRPML1, TRPML2, TRPML3, TRPM1 and TRPM8. Each expression plasmid encompassed full-length
sequences codon-optimized for S. cerevisiae with C-terminal TEV-GFP-His8-tag fusions (Figure 2A)
to enable visualization, affinity purification and quality control of generated targets. Constructs
were designed to employ the hybrid promoter (CG-P) of the pEMBLyex4 vector, enhanced by the
PAP1500 yeast production strain overexpressing the GAL4p transcriptional activator (Figure 2B) [42].
The potency of the system is further increased through selection for leucine autotrophy that significantly
increases the plasmid copy number prior to induction of the protein of interest [47].
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Figure 2. Schematic overview of the yeast production system. (A) Map of the employed plasmid
encoding the respective TRP channels fused C-terminally with a Tobacco Etch Virus, TEV, protease
cleavage site followed by green fluorescent protein sequence, GFP, attached to an octa-histidine stretch,
His8-tag (TEV-GFP-His8-tag). Other critical elements of the plasmid include 2µ (yeast 2 micron
origin of replication), leu2-d (poorly expressed allele of the β-iso-propyl-malate dehydrogenase
gene), bla (β-lactamase gene), pMB1 (pMB1origin of replication), URA3 (yeast orotidine-5’-phosphate
decarboxylase gene) and CG-P (hybrid promoter of GAL10 upstream activating sequence and 5’
non-translated leader of cytochrome-1 gene). (B) The Saccharomyces cerevisiae protein production strain
PAP1500 overexpresses the Gal4 transcriptional activator in the presence of galactose. Gal4 is the
limiting factor for expression from galactose regulated promoter. GAL10 p, UASgal, a specific DNA
binding site for GAL4 activator.
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3.2. Small-Scale Production and Localization in S. cerevisiae
As low protein yields obstruct most types of downstream studies, the obtained quantity of the
targets is critical to evaluate. Taking advantage of GFP detection of target accumulation permitted
by the fusion tag, we determined the produced levels of the 11 human TRP channels following 2-day
induction in 2-L cultures. By measuring whole-cell GFP fluorescence [48] and a GFP standard [49],
we estimated the target levels to range from 2.4 to 5.2 mg of protein per liter cell culture (Figure 3A),
representing rather promising yields for further optimization to produce samples for biophysical,
structural and drug discovery efforts. The highest protein levels were achieved for TRPC4, whereas
TRPML1 expressed the lowest, but still with encouraging yields.
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its SDS-resistance, and employed in-gel GFP fluor s nce (visible following SDS-PAGE), to visualize
the targets in crude membrane prep rations (Figure 3B). Encouragingly, all the asse sed 1 human TRP
chan els accumulated in the m mbranes i the full-length form. The electrophore ic mobility correla ed
Cells 2019, 8, 148 9 of 20
well with the predicted molecular weight, with TRPM1 representing the heaviest target (wild-type MW
of 198.7 kDa) and TRPML3 the lightest (wild-type MW of 57.7 kDa), respectively. For TRPC4 and TRPM1,
an additional weak fluorescent band of lower molecular mass was observed, indicating marginal protein
degradation. TRPM8 migrated as two fluorescent bands, reflecting monomeric and higher oligomeric
(here dimeric) forms. In addition, the appearance of an additional blurred and smeary band for TRPM8
may indicate posttranslational glycosylation as previously reported for this protein [50]. However, as
we achieved acceptable expression levels for this target, we did not attempt further optimization by
removing glycosylation sites that were previously reported to enhance protein secretion [51].
Based on these highly promising production levels and indicative sample quality, as well as
the fact that S. cerevisiae-based heterologous expression of well-behaving TRPV1 channel has been
reported [52], we decided to narrow our target portfolio to characterize further one selected member
from each subfamily, i.e., TRPC4, TRPV3, TRPML2 and TRPM8.
We then evaluated the localization of the produced human TRP channels in S. cerevisiae (Figure 3C).
As seen from live cell bioimaging fluorescent micrographs, TRPC4 and TRPML2 accumulate mainly
in the plasma membrane, whereas TRPV3 and TRPM8 reside in intra-cellular compartments.
Such target-specific compartmental differences in the protein accumulation are frequently observed
and do not affect the final quality of the produced samples [53].
3.3. Solubilization Screen and F-SEC
Successful chromatography purification of membrane proteins necessitates detergent(s) to enable
membrane extraction and stabilization in solution [54]. To identify the most suitable detergents for
solubilization of TRPC4, TRPV3, TRPML2 and TRPM8, we assessed several non-ionic (typically milder)
and zwitterionic (harsher) surfactants, but the majority displayed only partial extraction of the targets
(Supplementary Table S2). Overall, non-ionic DDM and DM (tested at a concentration of 2% w/w),
and zwitterionic FC-12 and FC-16 (1%) were the most efficient (Figure 4A), with the latter being able
to extract 4 TRP targets with at least 44% efficacy as observed for TRPML2. Interestingly, although
used at higher concentration, milder non-ionic DDM and DM were less effective, but still provided fair
solubilization, with only TRPM8 channel being extracted at lower, i.e., 20% efficacy, whereas the yield
for both TRPC4 and TRPV3 exceeded 40%. However, TRPML2 resisted solubilization with non-ionic
detergents and was only extracted with FC-12 and FC-16.
As already mentioned, an ideal extraction detergent should also maintain protein stability,
an essential factor for obtaining high-quality samples for most biochemical, biophysical and biomedical
applications. To evaluate protein behavior following exposure to detergent, we again took advantage
of the TEV-GFP-His8-tag and conducted F-SEC (Figure 4B–E) in presence of 0.03% DDM to minimize
aggregation of tested samples, where the SEC profile of the resulting solubilized fusion protein was
monitored by the fluorescence spectroscopy [55]. For each target two F-SEC runs were performed
to compare the profiles after solubilization with different detergents. In case of FC-16 all obtained
F-SEC profiles were sharp and symmetrical, suggesting that the TRP channels were monodispersed
in this detergent. Only for TRPC4 (Figure 4B) a small fraction of the protein eluted in the void
volume of the column, indicating partial aggregation. TRPC4 exhibited almost identical behavior in
DDM (Figure 4B), whereas the F-SEC profile for DDM-solubilized TRPM8 was broader, but devoid of
aggregation (Figure 4E). DM solubilization of TRPV3 revealed marginal aggregation and a main peak
elution across a relatively large volume span, suggesting partial disruption of the tetramer (Figure 4C).
The F-SEC profile of FC-12-solubilized TRPML2 demonstrated two major fluorescence peaks, indicating
dissociation of the oligomeric state towards a lower oligomeric (or monomeric) state (Figure 4D).
Considering the findings from the solubilization screen and F-SEC analysis, as well as previous
reports demonstrating that fos-cholines can be detrimental to membrane proteins [55,56], and the
fact that both DDM and DM are popular detergents for structural and functional studies (also
of TRP channels) [9,57], we decided to use primarily these milder surfactants for the subsequent
large-scale purifications.
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3.4. Purification
Affinity purification of the selected 4 targets was performed based on crude membranes isolated
from 40 g fermenter-grown S. cerevisiae cells (obtained from ~3 L of cell culture) induced for 96 h at
15 ◦C (Figure 5A–D). Membranes were solubilized for 3 h at 4 ◦C with the detergents indicated in
the respective panels of Figure 4, based on the prior F-SEC analysis. As observed from the respective
chromatograms, all TRP channels eluted at imidazole concentrations of ~250 mM. The total yield
of the purified protein ranged from 0.5 to 1.5 mg per liter cell culture (for TRPM8 and TRPV3,
respectively) and the overall purity already following the initial purification step was fair (see
insets with Coomassie-stained SDS-PAGE gels). We subsequently concentrated the top fractions
and attempted TEV protease facilitated removal of the GFP-His8-tag. However, only the TRPC4- and
TRPV3-fusions were successfully cleaved, whereas TRPML2 and TRPM8 remained refractory to the
TEV treatment (data not shown). This likely reflects poor accessibility of the C-termini in the two
latter constructs, preventing proteolytic activity. For TRPC4 and TRPV3, we performed reverse affinity
purification (R-IMAC), and obtained samples of higher purity as contaminants rebound to the resin
(data not shown).
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are indicated. IMAC profiles display UV280 signal for eluted protein (blue) and the corresponding 
imidazole gradients used for elution (green). Insets: Coomassie-stained SDS-PAGE gels with 
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The (reverse) affinity-purified TRP channels were subjected to SEC run with 3 × CMC of the 
corresponding detergents used for solubilization, to further verify the sample quality (Figure 6A–D). 
Tag-free TRPC4 eluted as a symmetric peak, indicating a high degree of homogeneity (Figure 6A). 
Similarly, although the SEC analysis of TRPV3 displayed some signs of aggregation, the overall shape 
and proportion suggested mono-dispersity of the sample (Figure 6B). We also obtained an acceptable 
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profiles display UV280 signal for eluted protein (blue) and the corresponding imidazole gradients
used for elution (green). Insets: Coomassie-stained SDS-PAGE gels with concentrated affinity-purified
samples. Black arrows indicate the MW for the corresponding fusion protein.
The (reverse) affinity-purified TRP channels were subjected to SEC run with 3 × CMC of the
corresponding detergents used for solubilization, to further verify the sample quality (Figure 6A–D).
Tag-free TRPC4 eluted as a symmetric peak, indicating a high degree of homogeneity (Figure 6A).
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Similarly, although the SEC analysis of TRPV3 displayed some signs of aggregation, the overall shape
and proportion suggested mono-dispersity of the sample (Figure 6B). We also obtained an acceptable
SEC profile for TRPML2, however, the main peak was preceded by a significant shoulder, indicating
the presence of higher oligomers (or even aggregation) in the sample (Figure 6C). The generated
SEC profile for TRPM8 was symmetric overall, hinting again at a high homogeneity of the purified
protein (Figure 6D).
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3.5. Single Channel Current Recordings of DDM-Solubilized TRPM8
Considering the relatively high predicted molecular weight, possible glycosylation, the lowest
extraction efficacy in milder detergents, hence the obtained protein yield, as well as its high medical
relevance, we nominated TRPM8 channel for functional characterization efforts. Current amplitude
was determined (Figure 7A,B) and plotted as a function of voltage (Vm) and a linear regression was
made to determine slope conductance, as shown in Figure 7C. The single channel conductance of
purified TRPM8 channels was determined to 56.9 ± 3.2 pS.
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4. Discussion
Membrane proteins, especially those of human origin, remain poorly understood relative to their
soluble counterparts and are underrepresented in protein structure databases, largely due to difficulties
in generation of prime-quality samples required for downstream efforts [58]. Furthermore, membrane
proteins represent very attractive drug targets, and thus, cheap, high-efficiency, easy-to-handle and
reproducible heterologous expression platforms capable of delivering large yields of recombinant
human membrane proteins are still highly demanded.
The most widely exploited system for production of TRP channels from higher organisms
is undoubtedly mammalian cell-based platforms that have provided several targets, including
TRPV1 [14], TRPV6 [19], TRPC3 [20], TRPC4 [22], TRPM2 [27], TRPM4 [28], TRPM8 [30], TRPML1 [25],
TRPA [11] and TRPPP2 [12]. However, complex growth requirements, high costs and modest yields
leave room for alternative approaches [35]. Nevertheless, hitherto only two of the available structures
of mammalian TRP channels, but none of human origin, originate from the protein produced in
S. cerevisiae [15,18]. Compared to the mammalian expression systems, S. cerevisiae offers higher
proteins yields, simpler culture conditions and significantly lower costs [59]. Importantly, as yeast
can commonly contaminate mammalian cell cultures, implementation of careful aseptic routines is,
however, necessary in laboratories culturing concomitantly these two types of cells [60].
In this study, we present a novel approach towards overproduction of human TRP channels
employing an S. cerevisiae-based heterologous expression system. This platform was already
successfully used for generation of several classes of membrane proteins, including the human
ether-à-go-go-related (ERG) channel [49] and aquaporins [61], and even sample that yielded the
first crystal structure of a human aquaglyceroporin [62]. Here, we approached the production of the
challenging human TRP channels in a systematic way, starting from design of suitable plasmids, yield
assessments, localization tests and solubilization screens, to affinity-based purification, SEC-based
analysis and functional characterization of one selected target.
The first critical step in the optimization of recombinant protein overproduction is to assemble
suitable expression plasmids [63]. Here, our strategy was based on the employment of full-length
human TRP channel sequences that were codon-optimized for S. cerevisiae, a common practice used to
improve production levels [64]. Moreover, all constructs possessed C-terminal TEV protease-detachable
GFP-His8-tags, enabling detection and affinity purification of the generated targets to facilitate
downstream characterization [48,65]. Furthermore, the expression vector used here encompassed
several important features, including the possibility to increase the plasmid copy number and an
inducible promoter [42]. Importantly, our strategy involved also the employment of a modified
S. cerevisiae strain that overexpresses the Gal4 transcriptional activator required for galactose induced
transcription [66]. Finally, we took advantage of the ability of S. cerevisiae to perform homologous
recombination to assemble the final constructs [67], a significant economical aspect of utilizing yeast.
The initial expression tests (Figure 3A,B) already indicated the power of our production strategy,
as we were able to recover all 11 human TRP channels selected for this study, all with promising
production yields reaching maximum 5.2 mg of accumulated protein per liter cell culture (Figure 3A).
Moreover, as evident from the in-gel GFP fluorescence signal, all targets were synthesized as
membrane-embedded full-length channels with only marginal signs of protein degradation (Figure 3B),
yet another important advantage of the utilized yeast platform. Moreover, for one target, namely
TRPM8, we observed indications of protein glycosylation (Figure 3B). It has been previously reported
that N-glycosylation is important for the function and regulation of TRP channels, including
TRPA [68], TRPC [69] and TRPM [70,71] subfamilies, respectively. S. cerevisiae PAP1500 strain utilized
here is capable of glycosylating the heterologously expressed human membrane proteins [49,61].
Of importance, S. cerevisiae has been shown to hyper-glycosylate proteins [36] with a detrimental impact
on expression levels [37,51]. Thus, additional optimization of employed constructs by engineering
glycosylation site(s) could be beneficial to further enhance the TRP channel production yields and
activity, however, it was not attempted here.
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The initial expression tests (Figure 3A,B) already indicated the power of our production strategy,
as we were able to recover all 11 human TRP channels selected for this study, all with promising
production yields reaching maximum 5.2 mg of accumulated protein per liter cell culture (Figure 3A).
Moreover, as evident from the in-gel GFP fluorescence signal, all targets were synthesized as
membrane-embedded full-length channels with only marginal signs of protein degradation (Figure 3B),
yet another important advantage of the utilized yeast platform. Moreover, for one target, namely
TRPM8, we observed indications of protein glycosylation (Figure 3B). It has been previously reported
that N-glycosylation is important for the function and regulation of TRP channels, including
TRPA [68], TRPC [69] and TRPM [70,71] subfamilies, respectively. S. cerevisiae PAP1500 strain utilized
here is capable of glycosylating the heterologously expressed human membrane proteins [49,61].
Of importance, S. cerevisiae has been shown to hyper-glycosylate proteins [36] with a detrimental impact
on expression levels [37,51]. Thus, additional optimization of employed constructs by engineering
glycosylation site(s) could be beneficial to further enhance the TRP channel production yields and
activity, however, it was not attempted here.
Mammalian TRP channels are known to differ in subcellular localization and, in addition to
the plasma membrane, can localize to intracellular membranes [72]. For four selected TRP channels,
we also observed differences in localization in the S. cerevisiae cells (Figure 3C), with TRPV3 and
TRPM8 accumulating mainly intracellularly. In accordance, intracellular membrane localization has
previously been observed for these two targets also in human cells [72,73].
To enable successful TRP channel production, suitable detergents for membrane extraction and
maintaining protein stability were identified. The initial choice of detergents for solubilization was
based on our previous large-scale analysis, which compared the efficacy of different compounds
for extracting overproduced human aquaporins using the same expression platform [61]. In the
solubilization screen presented here, we discovered that harsher zwitterionic detergents of the
fos-choline family displayed stronger extraction properties of human TRP channels from the S. cerevisiae
membranes as compared to milder non-ionic maltosides (Figure 4A, Supplementary Table S2). Indeed,
similar observations have also been reported for other membrane protein classes overexpressed in the
same host [74]. In general, all 4 targets tested here were rather resistant to solubilization, with only
TRPM8 channel demonstrating extraction efficacy in FC-16 exceeding 80%. Moreover, when using
FC-16, we observed slightly higher solubilization efficacy of the two targets accumulating in the
intracellular membranes (i.e., TRPV3 and TRPM8) as compared to TRPC3 and TRPML2 that localized
to the plasma membrane. A similar trend was previously reported for the human aquaporin family
produced using the same platform [61]. Fos-choline-solubilized material exhibited moderately more
symmetric F-SEC profiles, however, the mono-dispersity of the maltoside-extracted material was
also relatively high (Figure 4B–E), indicating that milder detergents are promising for isolation of
human TRP channels from crude S. cerevisiae membranes. This is also in agreement with the two
above-mentioned structural reports of human TRPV channels that were overproduced in S. cerevisiae
cells and solubilized in maltosides [15,18].
Affinity-based protein purification yielded milligram amounts of relatively pure samples already
following a single chromatography round (Figure 5A–D). Removal of GFP-His8-tag by TEV protease
cleavage followed by reverse affinity purification was successful for two out of four targets. However,
optimization of neither sequences of employed constructs nor cleavage conditions were attempted
here. The quality of (reverse) affinity-purified samples was evaluated by SEC performed with the
primary detergent, i.e., the respective detergent used for solubilization and affinity purification for
each target, respectively. Strikingly, all tested protein samples, including human TRPML2 isolated
using harsh FC-16, exhibited encouraging SEC profiles (Figure 6A–D).
In our final quality control test, we assessed whether human TRP channels produced using
the described overproduction approach preserved functionality, an important checkpoint for any
heterologous expression platform. DDM-solubilized human TRPM8 was selected as a representative
medically relevant target, with the aim to compare its conductance with permeation properties of
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TRPM8 isolated from other hosts. The slope conductance of TRPM8 reconstituted in lipid bilayers was
56.9 ± 3.2 pS (Figure 7C). Similar conductance (55 ± 3.9 pS) was found for TRPM8 from R. norvegicus
expressed in Xenopus laevis oocytes [75]. Moreover, a study employing human kidney cells reported
mean TRPM8 conductance of 72 ± 12 pS for outward currents, 42 ± 6 pS for inward currents,
respectively, and sub-conductance burst openings at 30 ± 3 pS, suggesting that the channel has
a strong outward rectification [76]. Thus, our functional data obtained for human TRPM8 isolated
from S. cerevisiae are in accordance with the conductance of both rat and human channels expressed in
higher eukaryotic heterologous systems, with subtle quantitative differences that likely are attributed
to variations of the experimental conditions.
All-in-all, obtained results establish our S. cerevisiae-based platform as a cost-effective and
high-throughput approach to produce milligram quantities of stable and functional human TRP
channels. Thus, the approach can be applied in functional, pharmacological and structural studies of
this important family of ion-conducting proteins.
Supplementary Materials: The following are available online at http://www.mdpi.com/2073-4409/8/2/148/s1,
Table S1: Sequences of primers used to obtain recombinant transient receptor potential (TRP) channel constructs
included in the study, Table S2: Solubilization of selected human TRP channels.
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